Navigation Links
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
Date:8/7/2009

. He served as product leader for that company's lead cancer compound to treat prostate and breast cancer.

"Metabolic disruption technology holds tremendous hope for patients with drug resistant tumors," said Haig Keledjian, CEO of Viral Genetics. "Dr. Trauger has worked in the biotech industry for 20 years and for the last 15 years has focused exclusively on bringing new cancer therapies to the clinic. We believe that he has the knowledge and experience to take this program forward. Creating a new corporation dedicated to that effort is critical to give this science the attention it deserves. At the same time, it enables Viral Genetics to remain focused on its core mission of pursuing treatments for autoimmune diseases, in addition to our primary focus of HIV and AIDS."

Viral Genetics has an option to acquire exclusive rights to the metabolic disruption technology from the University of Vermont and the University of Colorado, where the technology was invented and developed by Dr. Newell. Viral Genetics is completing negotiations to convert the option into an exclusive worldwide license covering a broad range of uses and specific therapeutic compositions.

Upon completion of certain benchmarks, Dr. Trauger will have the opportunity to acquire a 25% stake in the new company.

Viral Genetics has taken additional steps to strengthen its place in the marketplace by filing an unaudited financial statement at www.PinkSheets.com. That statement covers the company's financials for the last 18-months through March 31, 2009. Viral Genetics also recently retired a significant portion of its debt, enabling the majority of any new funding to go directly to bringing new drugs to the marketplace.

ABOUT VIRAL GENETICS:

Headquartered in San Marino, California, Viral Genetics discovers and develops
'/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances
2. Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website
3. New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance
4. BIO Visitors Bring Viral Preparedness to Atlanta
5. Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA
6. INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients
7. Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray
8. Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123
9. Researchers decode viral process that prepares cells for HIV infection
10. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
11. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... VANCOUVER , Oct. 22, 2014 /PRNewswire/ - iCo ... ICOTF), today announced next steps for its Oral ... findings from its in vitro work ... therapy.  iCo now plans to complete pre clinical ... an initial Phase 1A clinical trial, utilizing approximately ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 The ... (Medication Dispensing Systems, Packaging and Labeling Systems, Table-top ... Automation) - Global Forecasts & Trends to 2019” ... and opportunities in North America, Europe, Asia-Pacific, and ... 101 market tables and 30 figures spread through ...
(Date:10/20/2014)... 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the ... Q3 orders to $5.8 million and provides a good start to ... North America and one in the ... projects at record levels," said Peter Bruijns , President & ... end of Q3 than they have been for any complete year ...
(Date:10/20/2014)... October 20, 2014 OncLive® ... Kimmel Cancer Center at Thomas Jefferson University has ... Through the Strategic Alliance Partnership program, the Sidney ... collaborate to raise awareness of the Center’s cutting-edge ... other projects. Clinicians and other health care professionals ...
Breaking Biology Technology:iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3
... has often been called "a game of inches," but biology ... a few nanometers can determine the fate of a cell ... cancerous. Scientists with the U.S. Department of Energy (DOE),s Lawrence ... better way to study the impact of spatial patterns on ...
... Calif., Nov. 1, 2011 Epitomics, Inc., a ... has received a Notice of Allowance from the ... Method for Identifying Differentially Expressed Proteins (application 10/705,109). ... differentially expressed proteins in cell samples using libraries ...
... DIEGO, Nov. 1, 2011 Optimer Pharmaceuticals, Inc. (NASDAQ: ... will present at the 20th Annual Credit Suisse Healthcare ... Time (7:00 AM Pacific Time). (Logo:   ... the presentation will be accessible on the Investors page ...
Cached Biology Technology:Berkeley Lab scientists develop new tool for the study of spatial patterns in living cells 2Berkeley Lab scientists develop new tool for the study of spatial patterns in living cells 3
(Date:10/15/2014)... assess the pandemic risk from strains of influenza virus ... allow ourselves to become complacent that the most substantial ... scientists. , Influenza pandemics arise when a new virus ... widespread immunity – spreads in the human population. There ... years, the worst of which – the 1918 Spanish ...
(Date:10/15/2014)... to an unexpected extent. The outbreak does not follow ... shows a new disease dynamic in regions, where it ... German National Academy of Sciences Leopoldina, acatech – the ... of the German Academies of Sciences and Humanities have ... In the statement the academies call for the following ...
(Date:10/15/2014)... be awarded the 44th Rosenstiel Award for Distinguished Work ... research exploring the mechanisms of genomic instability and its ... is the second alumnus to win the Rosenstiel Award; ... 2003. , Alt is the Charles A. Janeway Professor ... School and an investigator at the Howard Hughes Medical ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
... Scientists from Hungary, Germany and the U.K. have discovered that ... the active ingredient in marijuana (THC), but these play ... on "endocannabinoids" just published online in, and scheduled for the ... could lead to new drugs that treat skin conditions ranging ...
... Fla. -- A Florida State University faculty member ... class of cancer-killing drugs is attracting worldwide attention ... assistant professor of chemical and biomedical engineering at ... Engineering, is using high-powered computers to determine how ...
... University have found that quantum dot nanoparticles can penetrate ... into potential workplace concerns for healthcare workers or individuals ... research on potential biomedical applications of the tiny nanoparticles. ... different sizes, shapes and surface coatings do not penetrate ...
Cached Biology News:FSU researcher using computers to hone cancer-fighting strategies 2Study shows quantum dots can penetrate skin through minor abrasions 2
... Biosearch Technologies has been at the ... accelerate the discovery and application of ... FRET probes and primers or 100 ... applications, Biosearch can meet your most ...
Cultrex 3D Culture Matrix Rat Collagen I....
UNIVERSAL SCORECARD DNA, 1 EA. * Category: Reagents/Consumables....
Cultrex 3D Culture Matrix Laminin I....
Biology Products: